These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 11050700)

  • 1. Comparison of the hematological effects of a sustained release chitosan formulation of pentoxifylline with a commercial formulation.
    Yamac K; Kaptan KM; Beyan C; Teksin ZS; Ağabeyoğlu IT; Gökgöz L
    Arzneimittelforschung; 2000 Sep; 50(9):827-31. PubMed ID: 11050700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release of pentoxifylline from porous chitosan-pectin scaffolds.
    Lin HY; Yeh CT
    Drug Deliv; 2010 Jul; 17(5):313-21. PubMed ID: 20370329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Pentoxifylline on inflammatory burden, oxidative stress and platelet aggregability in hypertensive type 2 diabetes mellitus patients.
    Maiti R; Agrawal NK; Dash D; Pandey BL
    Vascul Pharmacol; 2007; 47(2-3):118-24. PubMed ID: 17613279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetic analysis of novel sustained-release dosage forms of pentoxifylline in healthy subjects.
    Raz I; Ben-David J; Hussein Z; Samara E
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):206-8. PubMed ID: 3403100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pentoxifylline on platelet aggregation.
    Nenci GG; Gresele P; Agnelli G; Ballatori E
    Pharmatherapeutica; 1981; 2(8):532-8. PubMed ID: 7255510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution studies on tablets of ibuprofen using chitosan.
    Ilango R; Kavimani S; Jaykar B; Umamaheshwari G
    Indian J Exp Biol; 1999 May; 37(5):505-8. PubMed ID: 10492622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin.
    Hari PR; Chandy T; Sharma CP
    J Microencapsul; 1996; 13(3):319-29. PubMed ID: 8860687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of rotundine-chitosan gelled granules and their drug-release tests].
    Liu XJ; Xie SS; Zhang YX; Zhang JL; Zhang D; Wang YL; Ni D; Li D; Lu M; Ye QT
    Yao Xue Xue Bao; 1991; 26(10):782-7. PubMed ID: 1688072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of pentoxifylline on steady-state theophylline serum concentrations from sustained-release formulations.
    Ellison MJ; Horner RD; Willis SE; Cummings DM
    Pharmacotherapy; 1990; 10(6):383-6. PubMed ID: 2287557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of chitosan and hydroxypropylchitosan in drug formulations to effect sustained release.
    Machida Y; Nagai T; Abe M; Sannan T
    Drug Des Deliv; 1986 Nov; 1(2):119-30. PubMed ID: 3509325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan: a unique polysaccharide for drug delivery.
    Felt O; Buri P; Gurny R
    Drug Dev Ind Pharm; 1998 Nov; 24(11):979-93. PubMed ID: 9876553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of pentoxifylline and its main metabolites in patients with different degrees of heart failure following a single dose of a modified-release formulation.
    Nisi A; Panfili M; De Rosa G; Boffa G; Groppa F; Gusella M; Padrini R
    J Clin Pharmacol; 2013 Jan; 53(1):51-7. PubMed ID: 23400743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosing regimen and hematologic effects of pentoxifylline and its active metabolites in normal dogs.
    Rees CA; Boothe DM; Boeckh A; Wilkie S; Esparza T; Green R
    Vet Ther; 2003; 4(2):188-96. PubMed ID: 14506595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aspirin and propranolol alone and in combination on hemostatic determinants in the healthy cat.
    Allen DG; Johnstone IB; Crane S
    Am J Vet Res; 1985 Mar; 46(3):660-3. PubMed ID: 3994130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan microspheres of diclofenac sodium, II: In vitro and in vivo evaluation.
    Açikgöz M; Kaş HS; Hasçelik Z; Milli U; Hincal AA
    Pharmazie; 1995 Apr; 50(4):275-7. PubMed ID: 7792304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor.
    Hammerschmidt DE; Kotasek D; McCarthy T; Huh PW; Freyburger G; Vercellotti GM
    J Lab Clin Med; 1988 Aug; 112(2):254-63. PubMed ID: 2840477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of platelet aggregation in vivo. III. Effect of pentoxifylline.
    Gastpar H; Ambrus JL; Ambrus CM; Spavento P; Weber FJ; Thurber LE
    J Med; 1977; 8(3-4):191-7. PubMed ID: 407320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline.
    Ott E; Lechner H
    Ric Clin Lab; 1981; 11 Suppl 1():253-6. PubMed ID: 7188113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the carboxymethyl chitosan-containing liposomes for their stability and controlled release of dapsone.
    Alamelu S; Rao KP
    J Microencapsul; 1991; 8(4):505-19. PubMed ID: 1798021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research of the hemostasis effect of chitosan acetic acid solution].
    Tian F; Yang J; Chen S; Kan Y; Ji F
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Oct; 22(5):999-1003. PubMed ID: 16294739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.